JPWO2023081776A5 - - Google Patents
Info
- Publication number
- JPWO2023081776A5 JPWO2023081776A5 JP2024526594A JP2024526594A JPWO2023081776A5 JP WO2023081776 A5 JPWO2023081776 A5 JP WO2023081776A5 JP 2024526594 A JP2024526594 A JP 2024526594A JP 2024526594 A JP2024526594 A JP 2024526594A JP WO2023081776 A5 JPWO2023081776 A5 JP WO2023081776A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mol
- lipid
- section
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275402P | 2021-11-03 | 2021-11-03 | |
| US63/275,402 | 2021-11-03 | ||
| PCT/US2022/079244 WO2023081776A1 (en) | 2021-11-03 | 2022-11-03 | Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542099A JP2024542099A (ja) | 2024-11-13 |
| JP2024542099A5 JP2024542099A5 (https=) | 2025-11-12 |
| JPWO2023081776A5 true JPWO2023081776A5 (https=) | 2025-11-12 |
Family
ID=86242208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526594A Pending JP2024542099A (ja) | 2021-11-03 | 2022-11-03 | 核酸を含む脂質調合物、及び嚢胞性線維症の治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230159449A1 (https=) |
| EP (1) | EP4426266A4 (https=) |
| JP (1) | JP2024542099A (https=) |
| AU (1) | AU2022381750A1 (https=) |
| CA (1) | CA3236675A1 (https=) |
| WO (1) | WO2023081776A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12070509B2 (en) * | 2020-05-01 | 2024-08-27 | Arcturus Therapeutics, Inc. | Nucleic acids and methods of treatment for cystic fibrosis |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN117653606B (zh) * | 2023-11-14 | 2024-05-10 | 广东康百医药科技有限公司 | 一种间充质干细胞外泌体冻干保护剂及其应用 |
| WO2025111297A1 (en) * | 2023-11-21 | 2025-05-30 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| WO2025166323A2 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting lipoprotein (a) expression |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019013752A (es) * | 2017-05-16 | 2020-07-20 | Translate Bio Inc | Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones. |
| ES3039647T3 (en) * | 2017-05-31 | 2025-10-23 | Arcturus Therapeutics Inc | Synthesis and structure of high potency rna therapeutics |
| US12083224B2 (en) * | 2018-03-30 | 2024-09-10 | Arcturus Therapeutics, Inc. | Lipid particles for nucleic acid delivery |
| KR20210091120A (ko) * | 2018-08-29 | 2021-07-21 | 트랜슬레이트 바이오 인코포레이티드 | Mrna-로딩된 지질 나노입자를 제조하는 개선된 공정 |
| WO2021183563A1 (en) * | 2020-03-09 | 2021-09-16 | Arcturus Therapeutics, Inc. | Coronavirus vaccine compositions and methods |
-
2022
- 2022-11-03 EP EP22891055.0A patent/EP4426266A4/en active Pending
- 2022-11-03 WO PCT/US2022/079244 patent/WO2023081776A1/en not_active Ceased
- 2022-11-03 US US18/052,505 patent/US20230159449A1/en active Pending
- 2022-11-03 CA CA3236675A patent/CA3236675A1/en active Pending
- 2022-11-03 AU AU2022381750A patent/AU2022381750A1/en active Pending
- 2022-11-03 JP JP2024526594A patent/JP2024542099A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maruyama et al. | Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia | |
| Voinea et al. | Designing of ‘intelligent’liposomes for efficient delivery of drugs | |
| Allen et al. | Pharmacokinetics of long-circulating liposomes | |
| Lian et al. | Trends and developments in liposome drug delivery systems | |
| ES2366978T3 (es) | Nanocápsulas lipídicas furtivas, procedimientos para su preparación y utilización de las mismas como vehículo para principio(s) activo(s). | |
| Khuller et al. | Liposome technology for drug delivery against mycobacterial infections | |
| JPWO2021222801A5 (https=) | ||
| AU714043B2 (en) | Liposome-formulations for treatment of viral diseases | |
| JP2005502653A (ja) | 肺ガンの治療方法 | |
| CA2488385A1 (en) | Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) | |
| Mizuguchi et al. | Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth | |
| US6468558B2 (en) | Liposome-encapsulated poly ICLC | |
| IL302065A (en) | PAN-RAS mRNA CANCER VACCINES | |
| Oku et al. | Evaluation of drug targeting strategies and liposomal trafficking. | |
| JPWO2023081776A5 (https=) | ||
| JPWO2022235935A5 (https=) | ||
| US20050260260A1 (en) | Liposome compositions for the delivery of macromolecules | |
| Allen et al. | Sterically Stabilized (“Stealth”) | |
| EP0731703B1 (en) | Liposomal formulations containing vidarabine or its derivatives | |
| WO2004078121A2 (en) | Liposome composition for reduction of liposome-induced complement activation | |
| Katre | Liposome-based depot injection technologies: How versatile are they? | |
| KR20220149400A (ko) | 이황화 결합을 갖는 양이온성 지질을 사용하여 약물을 전달하기 위한 나노입자 조성물 및 그 제조방법 | |
| Bulbake et al. | Liposomal drug delivery system and its clinically available products | |
| Fielding et al. | Liposomes in the treatment of infectious diseases | |
| Katsumiiga et al. | Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake |